<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="MOESM2">
 <media xlink:href="13287_2018_904_MOESM2_ESM.tif" xmlns:xlink="http://www.w3.org/1999/xlink">
  <label>Additional file 2:</label>
  <caption>
   <p>
    <bold>Figure S1. (</bold>A) A flow chart of UC-MSC preparation for clinical use, including cell isolation, expansion, characterization, certification and safety assessment prior to transplantation. (B) Cell shapes at passages 1, 6 and 15. (C) Flow cytometry analysis of UC-MSCs showed high positive rates of CD105, CD73, CD90 and CD29, while CD45 and CD34 were negative. (D) Immunofluorescence of FABP, osteocalcin and aggrecan and immunohistochemical staining using Oil-red O, Alizarin Red and Alcian blue exhibited the presence of lipids, mineralized plaques and cartilaginous substrates derived from UC-MSCs, respectively. (TIF 4967Â kb)
   </p>
  </caption>
 </media>
</supplementary-material>
